NeuroSense Therapeutics Ltd.
|
-97 Thousand USD
|
469924.696%
|
Psyence Biomedical Ltd.
|
-240.00 USD
|
189887581.25%
|
XOMA Corporation
|
3.86 Million USD
|
-11703.418%
|
Mesoblast Limited
|
-9.81 Million USD
|
4743.199%
|
Xeris Biopharma Holdings, Inc.
|
135.26 Million USD
|
-236.906%
|
Aptorum Group Limited
|
-1.11 Million USD
|
40984.082%
|
Qualigen Therapeutics, Inc.
|
-4495.00 USD
|
10138697.442%
|
HilleVax, Inc.
|
-2.15 Million USD
|
21237.753%
|
Rocket Pharmaceuticals, Inc.
|
-7.09 Million USD
|
6520.54%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-31.16 Million USD
|
1562.189%
|
Precision BioSciences, Inc.
|
40.47 Million USD
|
-1026.038%
|
Dyadic International, Inc.
|
922.95 Thousand USD
|
-49277.16%
|
Intensity Therapeutics, Inc.
|
-147 Thousand USD
|
310120.378%
|
IDEAYA Biosciences, Inc.
|
-106.12 Million USD
|
529.436%
|
Eton Pharmaceuticals, Inc.
|
21.06 Million USD
|
-2063.857%
|
VYNE Therapeutics Inc.
|
424 Thousand USD
|
-107383.48%
|
EyePoint Pharmaceuticals, Inc.
|
41.38 Million USD
|
-1001.169%
|
Adaptive Biotechnologies Corporation
|
94.72 Million USD
|
-381.119%
|
Tenaya Therapeutics, Inc.
|
-8.68 Million USD
|
5346.114%
|
IGM Biosciences, Inc.
|
-211.66 Million USD
|
315.312%
|
Opthea Limited
|
21.72 Thousand USD
|
-2098104.213%
|
Milestone Pharmaceuticals Inc.
|
402 Thousand USD
|
-113265.66%
|
Abeona Therapeutics Inc.
|
2.43 Million USD
|
-18615.809%
|
Tonix Pharmaceuticals Holding Corp.
|
3.02 Million USD
|
-14955.499%
|
Ligand Pharmaceuticals Incorporated
|
119.75 Million USD
|
-280.558%
|
NextCure, Inc.
|
-3.68 Million USD
|
12470.52%
|
Inhibikase Therapeutics, Inc.
|
-13.35 Million USD
|
3511.702%
|
Ovid Therapeutics Inc.
|
-1.2 Million USD
|
37923.68%
|
CASI Pharmaceuticals, Inc.
|
20.05 Million USD
|
-2172.741%
|
Arcturus Therapeutics Holdings Inc.
|
154.79 Million USD
|
-194.416%
|
Syros Pharmaceuticals, Inc.
|
-98.21 Million USD
|
564.003%
|
Senti Biosciences, Inc.
|
-2.68 Million USD
|
17085.835%
|
Apollomics, Inc.
|
127 Thousand USD
|
-358742.484%
|
PureTech Health plc
|
-1.6 Million USD
|
28529.816%
|
Oncternal Therapeutics, Inc.
|
-28.96 Million USD
|
1673.219%
|
Barinthus Biotherapeutics plc
|
802 Thousand USD
|
-56724.184%
|
Kymera Therapeutics, Inc.
|
-110.48 Million USD
|
512.466%
|
ChromaDex Corporation
|
50.78 Million USD
|
-797.46%
|
Monopar Therapeutics Inc.
|
- USD
|
-Infinity%
|
Akebia Therapeutics, Inc.
|
120.47 Million USD
|
-278.281%
|
Sangamo Therapeutics, Inc.
|
-45.32 Million USD
|
1105.471%
|
Dermata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Gritstone bio, Inc.
|
-6.26 Million USD
|
7380.031%
|
Virpax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Fate Therapeutics, Inc.
|
-98.16 Million USD
|
564.258%
|
BioXcel Therapeutics, Inc.
|
120 Thousand USD
|
-379674.963%
|
Fortress Biotech, Inc.
|
57.85 Million USD
|
-687.738%
|
Checkpoint Therapeutics, Inc.
|
-43.46 Million USD
|
1148.547%
|
Atossa Therapeutics, Inc.
|
-23 Thousand USD
|
1981534.587%
|
Lyell Immunopharma, Inc.
|
130 Thousand USD
|
-350461.504%
|
Celcuity Inc.
|
-142.77 Thousand USD
|
319301.212%
|
ContextLogic Inc.
|
59 Million USD
|
-672.424%
|
GH Research PLC
|
-315 Thousand USD
|
144776.176%
|
HOOKIPA Pharma Inc.
|
16.57 Million USD
|
-2649.17%
|
Cassava Sciences, Inc.
|
-89.42 Million USD
|
609.634%
|
Cyclacel Pharmaceuticals, Inc.
|
389 Thousand USD
|
-117054.23%
|
ImmuCell Corporation
|
4.39 Million USD
|
-10266.254%
|
Amarin Corporation plc
|
165.54 Million USD
|
-175.297%
|
TG Therapeutics, Inc.
|
219.1 Million USD
|
-107.993%
|
X4 Pharmaceuticals, Inc.
|
-1.99 Million USD
|
22932.162%
|
Acelyrin, Inc.
|
-115 Thousand USD
|
396386.917%
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
Seer, Inc.
|
7.02 Million USD
|
-6385.413%
|
Novavax, Inc.
|
639.93 Million USD
|
28.785%
|
Phathom Pharmaceuticals, Inc.
|
515 Thousand USD
|
-88391.253%
|
Jazz Pharmaceuticals plc
|
3.39 Billion USD
|
86.591%
|
AnaptysBio, Inc.
|
14.78 Million USD
|
-2983.215%
|
Aptevo Therapeutics Inc.
|
-567 Thousand USD
|
80475.653%
|
PMV Pharmaceuticals, Inc.
|
-1.25 Million USD
|
36355.366%
|
AbCellera Biologics Inc.
|
38.02 Million USD
|
-1098.501%
|
CorMedix Inc.
|
-205.56 Thousand USD
|
221799.514%
|
Cartesian Therapeutics, Inc.
|
24.45 Million USD
|
-1763.85%
|
Marker Therapeutics, Inc.
|
-7.1 Million USD
|
6513.623%
|
Regeneron Pharmaceuticals, Inc.
|
11.3 Billion USD
|
95.967%
|
Aptose Biosciences Inc.
|
-474.54 Thousand USD
|
96135.14%
|
ZyVersa Therapeutics, Inc.
|
-10.4 Thousand USD
|
4382118.798%
|
Soligenix, Inc.
|
97.31 Thousand USD
|
-468223.165%
|
Century Therapeutics, Inc.
|
-10.8 Million USD
|
4316.208%
|
Arrowhead Pharmaceuticals, Inc.
|
240.73 Million USD
|
-89.308%
|
TransCode Therapeutics, Inc.
|
-516.74 Thousand USD
|
88292.256%
|
Kura Oncology, Inc.
|
-849 Thousand USD
|
53778.44%
|
RAPT Therapeutics, Inc.
|
-3.55 Million USD
|
12933.848%
|
Ardelyx, Inc.
|
106.66 Million USD
|
-327.27%
|
Ainos, Inc.
|
-253.73 Thousand USD
|
179710.045%
|
TScan Therapeutics, Inc.
|
-67.1 Million USD
|
779.14%
|
Ocean Biomedical, Inc.
|
- USD
|
-Infinity%
|
Prothena Corporation plc
|
-129.2 Million USD
|
452.729%
|
CytomX Therapeutics, Inc.
|
99.03 Million USD
|
-360.152%
|
Autolus Therapeutics plc
|
-4.86 Million USD
|
9463.673%
|
Mineralys Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Adaptimmune Therapeutics plc
|
50.42 Million USD
|
-803.797%
|
Eterna Therapeutics Inc.
|
-168 Thousand USD
|
271367.83%
|
Celularity Inc.
|
6.75 Million USD
|
-6646.557%
|
Rallybio Corporation
|
-150 Thousand USD
|
303919.97%
|
GRI Bio, Inc.
|
10.84 Million USD
|
-4103.763%
|
Xenetic Biosciences, Inc.
|
2.53 Million USD
|
-17842.223%
|
Omeros Corporation
|
-69.77 Million USD
|
753.105%
|
INmune Bio, Inc.
|
155 Thousand USD
|
-293919.326%
|
Heron Therapeutics, Inc.
|
61.93 Million USD
|
-635.772%
|
SAB Biotherapeutics, Inc.
|
-1.5 Million USD
|
30355.107%
|
Pasithea Therapeutics Corp.
|
-648.45 Thousand USD
|
70379.458%
|
Entero Therapeutics, Inc.
|
-29.27 Thousand USD
|
1556873.775%
|
Humacyte, Inc.
|
-76.55 Million USD
|
695.336%
|
Atara Biotherapeutics, Inc.
|
-313 Thousand USD
|
145700.625%
|
Coherus BioSciences, Inc.
|
94.46 Million USD
|
-382.453%
|
Immunocore Holdings plc
|
248.39 Million USD
|
-83.473%
|
Cocrystal Pharma, Inc.
|
-15.16 Million USD
|
3104.351%
|
Verastem, Inc.
|
-62 Thousand USD
|
735148.315%
|
Pliant Therapeutics, Inc.
|
-261 Thousand USD
|
174709.178%
|
Histogen Inc.
|
3.76 Million USD
|
-11991.535%
|
Surrozen, Inc.
|
-27.23 Million USD
|
1773.632%
|
Blueprint Medicines Corporation
|
236.58 Million USD
|
-92.629%
|
Organovo Holdings, Inc.
|
-5.38 Million USD
|
8556.67%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
IO Biotech, Inc.
|
-756 Thousand USD
|
60381.74%
|
MEI Pharma, Inc.
|
49.32 Million USD
|
-823.896%
|
GT Biopharma, Inc.
|
- USD
|
-Infinity%
|
Centessa Pharmaceuticals plc
|
6.06 Million USD
|
-7412.334%
|
Hepion Pharmaceuticals, Inc.
|
-67.13 Thousand USD
|
678966.626%
|
Cabaletta Bio, Inc.
|
-1.42 Million USD
|
32058.622%
|
Summit Therapeutics Inc.
|
-2.05 Million USD
|
22330.73%
|
Alaunos Therapeutics, Inc.
|
-4.79 Million USD
|
9598.332%
|
Marinus Pharmaceuticals, Inc.
|
29.05 Million USD
|
-1468.508%
|
BioRestorative Therapies, Inc.
|
145.8 Thousand USD
|
-312471.986%
|
Turnstone Biologics Corp.
|
16.5 Million USD
|
-2660.996%
|
Pulmatrix, Inc.
|
-8.22 Million USD
|
5644.16%
|
Synaptogenix, Inc.
|
-6347.00 USD
|
7180341.925%
|
Tiziana Life Sciences Ltd
|
-51 Thousand USD
|
893688.147%
|
Aurinia Pharmaceuticals Inc.
|
161.36 Million USD
|
-182.422%
|
Vigil Neuroscience, Inc.
|
-399 Thousand USD
|
114318.034%
|
Intellia Therapeutics, Inc.
|
-398.79 Million USD
|
214.277%
|
Cytokinetics, Incorporated
|
-322.59 Million USD
|
241.271%
|
Exelixis, Inc.
|
1.75 Billion USD
|
74.072%
|
Nurix Therapeutics, Inc.
|
-112.16 Million USD
|
506.318%
|
Apellis Pharmaceuticals, Inc.
|
338.08 Million USD
|
-34.799%
|
Evogene Ltd.
|
1.39 Million USD
|
-32475.408%
|
Replimune Group, Inc.
|
-2.65 Million USD
|
17264.97%
|
PDS Biotechnology Corporation
|
-57.32 Thousand USD
|
795079.512%
|
Hoth Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Jasper Therapeutics, Inc.
|
-1.1 Million USD
|
41230.862%
|
ESSA Pharma Inc.
|
-118.49 Thousand USD
|
384711.452%
|
TNF Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
BioLineRx Ltd.
|
1.1 Million USD
|
-41030.862%
|
Avid Bioservices, Inc.
|
7.31 Million USD
|
-6127.52%
|
Insmed Incorporated
|
239.63 Million USD
|
-90.177%
|
VistaGen Therapeutics, Inc.
|
496 Thousand USD
|
-91781.039%
|
Zentalis Pharmaceuticals, Inc.
|
-1.38 Million USD
|
32909.932%
|
Sagimet Biosciences Inc.
|
2 Million USD
|
-22686.498%
|
MediWound Ltd.
|
3.57 Million USD
|
-12637.003%
|
MiMedx Group, Inc.
|
266.84 Million USD
|
-70.786%
|
OmniAb, Inc.
|
14.66 Million USD
|
-3007.179%
|
Alector, Inc.
|
-95.05 Million USD
|
579.448%
|
Seres Therapeutics, Inc.
|
125.62 Million USD
|
-262.782%
|
PTC Therapeutics, Inc.
|
872.33 Million USD
|
47.758%
|
Mereo BioPharma Group plc
|
7.42 Million USD
|
-6036.951%
|
Zai Lab Limited
|
170.9 Million USD
|
-166.66%
|
Revance Therapeutics, Inc.
|
81.87 Million USD
|
-456.603%
|
Syndax Pharmaceuticals, Inc.
|
-12 Thousand USD
|
3797849.625%
|
Aura Biosciences, Inc.
|
-1.29 Million USD
|
35291.502%
|
Immunic, Inc.
|
-111 Thousand USD
|
410667.527%
|
Dyne Therapeutics, Inc.
|
-2.46 Million USD
|
18618.08%
|
Tarsus Pharmaceuticals, Inc.
|
15.85 Million USD
|
-2774.542%
|
Veracyte, Inc.
|
248.14 Million USD
|
-83.652%
|
InMed Pharmaceuticals Inc.
|
-6.98 Billion USD
|
106.521%
|
FibroGen, Inc.
|
128.9 Million USD
|
-253.542%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
Allakos Inc.
|
-6.14 Million USD
|
7521.103%
|
scPharmaceuticals Inc.
|
9.78 Million USD
|
-4558.863%
|
Fulcrum Therapeutics, Inc.
|
-68.99 Million USD
|
760.516%
|
Corcept Therapeutics Incorporated
|
475.89 Million USD
|
4.237%
|
Adial Pharmaceuticals, Inc.
|
-564.00 USD
|
80803283.511%
|
NLS Pharmaceutics AG
|
-11.4 Thousand USD
|
3994927.796%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-11.66 Million USD
|
4006.184%
|
Amylyx Pharmaceuticals, Inc.
|
355.34 Million USD
|
-28.25%
|
Precigen, Inc.
|
106 Thousand USD
|
-429833.92%
|
Fortrea Holdings Inc.
|
424 Million USD
|
-7.483%
|
KalVista Pharmaceuticals, Inc.
|
-86.16 Million USD
|
628.892%
|
Incyte Corporation
|
3.44 Billion USD
|
86.755%
|
Alzamend Neuro, Inc.
|
-50.74 Thousand USD
|
898267.038%
|
Cara Therapeutics, Inc.
|
14.79 Million USD
|
-2980.505%
|
XBiotech Inc.
|
-1.74 Million USD
|
26231.305%
|
Aligos Therapeutics, Inc.
|
12.46 Million USD
|
-3557.544%
|
Jasper Therapeutics, Inc.
|
-1.1 Million USD
|
41230.862%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
CRISPR Therapeutics AG
|
240.95 Million USD
|
-89.134%
|
Akero Therapeutics, Inc.
|
-29 Thousand USD
|
1571582.603%
|
Eliem Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Lyra Therapeutics, Inc.
|
-46.47 Million USD
|
1080.676%
|
Foghorn Therapeutics Inc.
|
-75.53 Million USD
|
703.344%
|
Agenus Inc.
|
139.61 Million USD
|
-226.419%
|
Kiora Pharmaceuticals, Inc.
|
-4.02 Million USD
|
11416.756%
|
Y-mAbs Therapeutics, Inc.
|
73.4 Million USD
|
-520.86%
|
Theravance Biopharma, Inc.
|
16.8 Million USD
|
-2612.194%
|
Ultragenyx Pharmaceutical Inc.
|
389.04 Million USD
|
-17.142%
|
Metagenomi, Inc. Common Stock
|
-49.64 Million USD
|
1017.941%
|
Lexaria Bioscience Corp.
|
194.7 Thousand USD
|
-233958.156%
|
BioCryst Pharmaceuticals, Inc.
|
326.75 Million USD
|
-39.473%
|
UroGen Pharma Ltd.
|
73.35 Million USD
|
-521.292%
|
Gain Therapeutics, Inc.
|
-11.32 Million USD
|
4124.517%
|
Sutro Biopharma, Inc.
|
-26.69 Million USD
|
1807.237%
|
Creative Medical Technology Holdings, Inc.
|
5400.00 USD
|
-8439343.611%
|
Lisata Therapeutics, Inc.
|
-189 Thousand USD
|
241226.96%
|
Chemomab Therapeutics Ltd.
|
-66.82 Thousand USD
|
682054.831%
|
Stoke Therapeutics, Inc.
|
4.05 Million USD
|
-11149.814%
|
Chimerix, Inc.
|
324 Thousand USD
|
-140557.394%
|
Reneo Pharmaceuticals, Inc.
|
-525 Thousand USD
|
86905.706%
|
Outlook Therapeutics, Inc.
|
-44.18 Thousand USD
|
1031443.249%
|
60 Degrees Pharmaceuticals, Inc.
|
-220.97 Thousand USD
|
206334.113%
|
Pluri Inc.
|
322 Thousand USD
|
-141431.042%
|
Cue Biopharma, Inc.
|
-32.6 Million USD
|
1497.645%
|
MeiraGTx Holdings plc
|
287 Thousand USD
|
-158690.925%
|
Aprea Therapeutics, Inc.
|
576.17 Thousand USD
|
-78995.204%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-1980.00 USD
|
23016764.394%
|
Cidara Therapeutics, Inc.
|
62.38 Million USD
|
-630.547%
|
ProMIS Neurosciences, Inc.
|
-10.44 Million USD
|
4463.158%
|
CalciMedica, Inc.
|
-58 Thousand USD
|
785841.302%
|
Scholar Rock Holding Corporation
|
-2.84 Million USD
|
16124.26%
|
Sana Biotechnology, Inc.
|
-30.86 Million USD
|
1576.527%
|
Elicio Therapeutics, Inc.
|
-1.17 Million USD
|
39051.278%
|
NLS Pharmaceutics AG
|
-11.4 Thousand USD
|
3994927.796%
|
Adlai Nortye Ltd. American Depositary Shares
|
2.77 Million USD
|
-16319.24%
|
Nutriband Inc.
|
862.1 Thousand USD
|
-52762.465%
|
Protara Therapeutics, Inc.
|
-341 Thousand USD
|
133745.148%
|
Vor Biopharma Inc.
|
-3.49 Million USD
|
13150.686%
|
Roivant Sciences Ltd.
|
109.23 Million USD
|
-317.201%
|
ProKidney Corp.
|
-3.16 Million USD
|
14480.876%
|
Applied Therapeutics, Inc.
|
-43.91 Million USD
|
1137.826%
|
Daré Bioscience, Inc.
|
2.76 Million USD
|
-16355.185%
|
BridgeBio Pharma, Inc.
|
6.85 Million USD
|
-6546.2%
|
Titan Pharmaceuticals, Inc.
|
-1.72 Million USD
|
26458.008%
|
Bicycle Therapeutics plc
|
-129.52 Million USD
|
451.861%
|
Tango Therapeutics, Inc.
|
-78.67 Million USD
|
679.286%
|
Galectin Therapeutics Inc.
|
-33 Thousand USD
|
1381099.864%
|
Revolution Medicines, Inc. Warrant
|
-399.66 Million USD
|
214.028%
|
Atai Life Sciences N.V.
|
-5000.00 USD
|
9114699.1%
|
Renovaro Biosciences Inc.
|
-121.85 Thousand USD
|
374081.368%
|
Aerovate Therapeutics, Inc.
|
-96 Thousand USD
|
474818.703%
|
MediciNova, Inc.
|
979.7 Thousand USD
|
-46417.059%
|
Praxis Precision Medicines, Inc.
|
-84.31 Million USD
|
640.483%
|
Cardio Diagnostics Holdings, Inc.
|
-94.55 Thousand USD
|
482073.407%
|
GeoVax Labs, Inc.
|
-20.72 Million USD
|
2299.388%
|
Protagonist Therapeutics, Inc.
|
56.68 Million USD
|
-703.927%
|
Axsome Therapeutics, Inc.
|
244.53 Million USD
|
-86.366%
|
Biomea Fusion, Inc.
|
-4.2 Million USD
|
10948.13%
|
RenovoRx, Inc.
|
- USD
|
-Infinity%
|
Erasca, Inc.
|
-3.73 Million USD
|
12311.414%
|
Cullinan Oncology, Inc.
|
-310 Thousand USD
|
147109.663%
|
NRx Pharmaceuticals, Inc.
|
-5000.00 USD
|
9114699.1%
|
4D Molecular Therapeutics, Inc.
|
-76.37 Million USD
|
696.716%
|
Kiniksa Pharmaceuticals, Ltd.
|
213.73 Million USD
|
-113.222%
|
bluebird bio, Inc.
|
-4.03 Million USD
|
11408.436%
|
Ventyx Biosciences, Inc.
|
-941 Thousand USD
|
48530.388%
|
Pieris Pharmaceuticals, Inc.
|
1 Million USD
|
-45066.497%
|
Imunon, Inc.
|
-720 Thousand USD
|
63395.388%
|
BioMarin Pharmaceutical Inc.
|
1.9 Billion USD
|
76.069%
|
BioAtla, Inc.
|
-103.73 Million USD
|
539.338%
|
Allogene Therapeutics, Inc.
|
-242.81 Million USD
|
287.683%
|
Larimar Therapeutics, Inc.
|
-311 Thousand USD
|
146636.963%
|
DBV Technologies S.A.
|
15.72 Million USD
|
-2797.571%
|
Fortress Biotech, Inc.
|
57.85 Million USD
|
-687.738%
|
Avidity Biosciences, Inc.
|
-181.4 Million USD
|
351.218%
|
Kezar Life Sciences, Inc.
|
-70.08 Million USD
|
750.253%
|
aTyr Pharma, Inc.
|
-2.38 Million USD
|
19184.169%
|
Viridian Therapeutics, Inc.
|
-1 Million USD
|
45311.305%
|
EyeGate Pharmaceuticals, Inc.
|
13.00 USD
|
-3505614938.462%
|
Galecto, Inc.
|
-830 Thousand USD
|
55007.223%
|
Akari Therapeutics, Plc
|
-4000.00 USD
|
11393348.875%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
Halozyme Therapeutics, Inc.
|
636.89 Million USD
|
28.445%
|
Lexicon Pharmaceuticals, Inc.
|
1.11 Million USD
|
-40626.538%
|
Entera Bio Ltd.
|
-56 Thousand USD
|
813903.491%
|
Travere Therapeutics, Inc.
|
133.78 Million USD
|
-240.636%
|
Sensei Biotherapeutics, Inc.
|
-571 Thousand USD
|
79912.602%
|
Xencor, Inc.
|
-85.26 Million USD
|
634.518%
|
Orchestra BioMed Holdings, Inc.
|
2.57 Million USD
|
-17605.126%
|
Spruce Biosciences, Inc.
|
-39.34 Million USD
|
1258.351%
|
Coeptis Therapeutics Holdings, Inc.
|
-1 Million USD
|
45616.737%
|
Vanda Pharmaceuticals Inc.
|
177.84 Million USD
|
-156.253%
|
Lexaria Bioscience Corp.
|
194.7 Thousand USD
|
-233958.156%
|
Portage Biotech Inc.
|
-54 Thousand USD
|
844044.361%
|
Cardio Diagnostics Holdings, Inc.
|
-94.55 Thousand USD
|
482073.407%
|
Olema Pharmaceuticals, Inc.
|
-377 Thousand USD
|
120983.277%
|
OncoCyte Corporation
|
413 Thousand USD
|
-110246.236%
|
Processa Pharmaceuticals, Inc.
|
-222.00 USD
|
205283863.514%
|
Purple Biotech Ltd.
|
-196 Thousand USD
|
232615.283%
|
CollPlant Biotechnologies Ltd.
|
8.96 Million USD
|
-4981.735%
|
Onconetix, Inc.
|
-1.12 Million USD
|
40531.521%
|
MacroGenics, Inc.
|
50.52 Million USD
|
-801.953%
|
Tharimmune, Inc.
|
- USD
|
-Infinity%
|
Genprex, Inc.
|
-15 Thousand USD
|
3037489.729%
|
Apogee Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Neumora Therapeutics, Inc. Common Stock
|
-668 Thousand USD
|
68323.047%
|
Ocuphire Pharma, Inc.
|
19.04 Million USD
|
-2293.163%
|
Prime Medicine, Inc.
|
-147.9 Million USD
|
408.123%
|
Aditxt, Inc.
|
-111.66 Thousand USD
|
408240.744%
|
XTL Biopharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
Virios Therapeutics, Inc.
|
- USD
|
-Infinity%
|
OKYO Pharma Limited
|
-7506.16 USD
|
6071512.746%
|
Savara Inc.
|
-44.26 Million USD
|
1129.619%
|
Curis, Inc.
|
9.81 Million USD
|
-4545.092%
|
Carmell Therapeutics Corporation
|
-124.78 Thousand USD
|
365303.349%
|
Adagene Inc.
|
18.11 Million USD
|
-2416.248%
|
Achieve Life Sciences, Inc.
|
-228 Thousand USD
|
199981.559%
|
BeiGene, Ltd.
|
2.07 Billion USD
|
78.078%
|
Inhibrx Biosciences, Inc.
|
609 Thousand USD
|
-74732.505%
|
GlycoMimetics, Inc.
|
-143.3 Thousand USD
|
318122.871%
|
Maravai LifeSciences Holdings, Inc.
|
140.2 Million USD
|
-225.052%
|
Protagenic Therapeutics, Inc.
|
-28.21 Thousand USD
|
1615132.798%
|
SciSparc Ltd.
|
2.19 Million USD
|
-20652.73%
|
Protagenic Therapeutics, Inc.
|
-28.21 Thousand USD
|
1615132.798%
|
Vincerx Pharma, Inc.
|
-915 Thousand USD
|
49906.552%
|
Revelation Biosciences, Inc.
|
-25.04 Thousand USD
|
1819453.886%
|
Minerva Neurosciences, Inc.
|
-30.98 Thousand USD
|
1471050.729%
|
Fresh Tracks Therapeutics, Inc.
|
8 Million USD
|
-5592.355%
|
Arcutis Biotherapeutics, Inc.
|
54.61 Million USD
|
-734.38%
|
Acrivon Therapeutics, Inc. Common Stock
|
-536 Thousand USD
|
85124.245%
|
Alnylam Pharmaceuticals, Inc.
|
1.51 Billion USD
|
69.976%
|
ADMA Biologics, Inc.
|
88.21 Million USD
|
-416.595%
|
Rigel Pharmaceuticals, Inc.
|
109.77 Million USD
|
-315.16%
|
Clene Inc.
|
533 Thousand USD
|
-85402.806%
|
Celldex Therapeutics, Inc.
|
-111.12 Million USD
|
510.095%
|
Cogent Biosciences, Inc.
|
-3.58 Million USD
|
12801.504%
|
Boundless Bio, Inc. Common Stock
|
-957 Thousand USD
|
47720.685%
|
Recursion Pharmaceuticals, Inc.
|
1.98 Million USD
|
-22824.042%
|
Adicet Bio, Inc.
|
-6.09 Million USD
|
7573.433%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
49.8 Million USD
|
-815.029%
|
Absci Corporation
|
-41.84 Million USD
|
1188.986%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
Quantum-Si incorporated
|
488 Thousand USD
|
-93287.286%
|
Acurx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Voyager Therapeutics, Inc.
|
157.83 Million USD
|
-188.736%
|
Surrozen, Inc.
|
-27.23 Million USD
|
1773.632%
|
Generation Bio Co.
|
-73.91 Million USD
|
716.593%
|
Astria Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Caribou Biosciences, Inc.
|
-77.59 Million USD
|
687.296%
|
Black Diamond Therapeutics, Inc.
|
-437 Thousand USD
|
104386.031%
|
Janux Therapeutics, Inc.
|
-46.83 Million USD
|
1072.971%
|
Invivyd, Inc.
|
-2.02 Million USD
|
22571.891%
|
Cingulate Inc.
|
-582.91 Thousand USD
|
78280.8%
|
Relay Therapeutics, Inc.
|
-300.84 Million USD
|
251.485%
|
Quoin Pharmaceuticals, Ltd.
|
-103.43 Thousand USD
|
440682.721%
|
Tenax Therapeutics, Inc.
|
-7570.00 USD
|
6020310.766%
|
Spero Therapeutics, Inc.
|
96.36 Million USD
|
-372.906%
|
Jaguar Health, Inc.
|
7.72 Million USD
|
-5800.181%
|
Artelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
2seventy bio, Inc.
|
98.28 Million USD
|
-363.668%
|
Clearside Biomedical, Inc.
|
7.87 Million USD
|
-5689.988%
|
Terns Pharmaceuticals, Inc.
|
-881 Thousand USD
|
51828.712%
|
ACADIA Pharmaceuticals Inc.
|
680.7 Million USD
|
33.05%
|
Capricor Therapeutics, Inc.
|
24.1 Million USD
|
-1790.275%
|
Citius Pharmaceuticals, Inc.
|
-194.31 Thousand USD
|
234630.329%
|
Relmada Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Kronos Bio, Inc.
|
1.37 Million USD
|
-33116.469%
|
Innoviva, Inc.
|
261.06 Million USD
|
-74.566%
|
Bolt Biotherapeutics, Inc.
|
-53.66 Million USD
|
949.197%
|
Entrada Therapeutics, Inc.
|
29.12 Million USD
|
-1464.523%
|
ALX Oncology Holdings Inc.
|
-836 Thousand USD
|
54613.153%
|
Vir Biotechnology, Inc.
|
83.41 Million USD
|
-446.341%
|
Evaxion Biotech A/S
|
73.11 Thousand USD
|
-623231.266%
|
Ocular Therapeutix, Inc.
|
53.16 Million USD
|
-757.248%
|
Verve Therapeutics, Inc.
|
-173.18 Million USD
|
363.142%
|
Tyra Biosciences, Inc.
|
-353 Thousand USD
|
129201.97%
|
Galmed Pharmaceuticals Ltd.
|
-31 Thousand USD
|
1470196.629%
|
Unity Biotechnology, Inc.
|
-19.69 Million USD
|
2413.467%
|
Connect Biopharma Holdings Limited
|
-988 Thousand USD
|
46226.514%
|
Clearmind Medicine Inc.
|
-56.34 Thousand USD
|
808963.645%
|
AlloVir, Inc.
|
-398 Thousand USD
|
114605.014%
|
ORIC Pharmaceuticals, Inc.
|
-1.03 Million USD
|
44259.879%
|
Catalyst Pharmaceuticals, Inc.
|
313.67 Million USD
|
-45.289%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Viking Therapeutics, Inc.
|
-292 Thousand USD
|
156171.902%
|
Keros Therapeutics, Inc.
|
-664 Thousand USD
|
68734.029%
|
SELLAS Life Sciences Group, Inc.
|
- USD
|
-Infinity%
|
Crinetics Pharmaceuticals, Inc.
|
4.01 Million USD
|
-11256.341%
|
ImmunityBio, Inc.
|
-17.89 Million USD
|
2647.401%
|
Korro Bio, Inc.
|
-3.63 Million USD
|
12654.544%
|
C4 Therapeutics, Inc.
|
-96.95 Million USD
|
570.067%
|
Kineta, Inc.
|
5.43 Million USD
|
-8288.182%
|
Lantern Pharma Inc.
|
-174.84 Thousand USD
|
260750.958%
|
BioVie Inc.
|
-229.37 Thousand USD
|
198781.627%
|
Codexis, Inc.
|
57.33 Million USD
|
-694.869%
|
Celularity Inc.
|
6.75 Million USD
|
-6646.557%
|
Eledon Pharmaceuticals, Inc.
|
-374 Thousand USD
|
121952.929%
|
Virax Biolabs Group Limited
|
50.59 Thousand USD
|
-900730.115%
|
Kodiak Sciences Inc.
|
-25.94 Million USD
|
1856.388%
|
Cibus, Inc.
|
1.42 Million USD
|
-31948.52%
|
Annexon, Inc.
|
-3.26 Million USD
|
14049.494%
|
Assembly Biosciences, Inc.
|
-41.73 Million USD
|
1191.909%
|
Moderna, Inc.
|
2.15 Billion USD
|
78.852%
|
Ionis Pharmaceuticals, Inc.
|
778.51 Million USD
|
41.462%
|
Adverum Biotechnologies, Inc.
|
-2.04 Million USD
|
22395.986%
|
Avalo Therapeutics, Inc.
|
640 Thousand USD
|
-71107.805%
|
Immix Biopharma, Inc.
|
-5468.00 USD
|
8334590.764%
|
Eyenovia, Inc.
|
- USD
|
-Infinity%
|
Puma Biotechnology, Inc.
|
172.95 Million USD
|
-163.496%
|
Monte Rosa Therapeutics, Inc.
|
-6.22 Million USD
|
7424.493%
|
Wave Life Sciences Ltd.
|
104.09 Million USD
|
-337.785%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Xilio Therapeutics, Inc.
|
-1.9 Million USD
|
24085.787%
|
Alkermes plc
|
1.37 Billion USD
|
66.848%
|
Arcellx, Inc.
|
108.27 Million USD
|
-320.885%
|
Moolec Science SA
|
-143.3 Thousand USD
|
318113.995%
|
Cardiff Oncology, Inc.
|
-32.36 Million USD
|
1507.921%
|
LAVA Therapeutics N.V.
|
3.28 Million USD
|
-13764.617%
|
Enanta Pharmaceuticals, Inc.
|
79.2 Million USD
|
-475.388%
|
Regulus Therapeutics Inc.
|
-21.15 Million USD
|
2254.548%
|
Atea Pharmaceuticals, Inc.
|
-70.09 Million USD
|
750.207%
|
Compass Therapeutics, Inc.
|
-1.89 Million USD
|
24212.696%
|
Greenwich LifeSciences, Inc.
|
-3612.00 USD
|
12617208.389%
|
Humacyte, Inc.
|
-76.55 Million USD
|
695.336%
|
Acumen Pharmaceuticals, Inc.
|
-42.31 Million USD
|
1176.918%
|
Geron Corporation
|
-123.5 Million USD
|
469.003%
|
Verrica Pharmaceuticals Inc.
|
4.37 Million USD
|
-10309.547%
|
Avenue Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Royalty Pharma plc
|
1.79 Billion USD
|
74.596%
|
TFF Pharmaceuticals, Inc.
|
231.39 Thousand USD
|
-196852.325%
|
Notable Labs, Ltd.
|
113 Thousand USD
|
-403200.845%
|
Mersana Therapeutics, Inc.
|
-111.41 Million USD
|
509.042%
|
Structure Therapeutics Inc.
|
-949.17 Thousand USD
|
48113.321%
|
IN8bio, Inc.
|
-2.5 Million USD
|
18321.909%
|
89bio, Inc.
|
-273 Thousand USD
|
167034.049%
|
DiaMedica Therapeutics Inc.
|
-30 Thousand USD
|
1519199.85%
|
Vera Therapeutics, Inc.
|
1.86 Million USD
|
-24375.293%
|
Acasti Pharma Inc.
|
-11 Thousand USD
|
4143099.591%
|
Genelux Corporation
|
-848 Thousand USD
|
53841.74%
|
Trevi Therapeutics, Inc.
|
-123 Thousand USD
|
370612.159%
|
Liquidia Corporation
|
14.6 Million USD
|
-3021.438%
|
Mustang Bio, Inc.
|
-2.22 Million USD
|
20582.245%
|
Immunovant, Inc.
|
-231 Thousand USD
|
197385.695%
|
Vericel Corporation
|
135.57 Million USD
|
-236.144%
|
Quantum-Si incorporated
|
488 Thousand USD
|
-93287.286%
|
Arbutus Biopharma Corporation
|
-55.55 Million USD
|
920.263%
|
XOMA Corporation
|
3.86 Million USD
|
-11703.418%
|
ARS Pharmaceuticals, Inc.
|
-20.03 Million USD
|
2374.556%
|
MiNK Therapeutics, Inc.
|
-204.61 Thousand USD
|
222823.408%
|
Pasithea Therapeutics Corp.
|
-648.45 Thousand USD
|
70379.458%
|
Alpha Tau Medical Ltd.
|
-1.07 Million USD
|
42532.957%
|
Vaxcyte, Inc.
|
-75 Million USD
|
707.64%
|
Xenon Pharmaceuticals Inc.
|
-167.51 Million USD
|
372.058%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
NeuroBo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Tempest Therapeutics, Inc.
|
-381 Thousand USD
|
119714.161%
|
Sol-Gel Technologies Ltd.
|
-21.98 Million USD
|
2172.725%
|
Rhythm Pharmaceuticals, Inc.
|
68.12 Million USD
|
-568.952%
|
Soleno Therapeutics, Inc.
|
-1.95 Million USD
|
23375.279%
|
Enlivex Therapeutics Ltd.
|
-835 Thousand USD
|
54678.438%
|
PepGen Inc.
|
-1.18 Million USD
|
38590.706%
|
Moleculin Biotech, Inc.
|
-127 Thousand USD
|
358942.484%
|
United Therapeutics Corporation
|
2.07 Billion USD
|
77.984%
|
Solid Biosciences Inc.
|
-76.56 Million USD
|
695.235%
|
BriaCell Therapeutics Corp.
|
-82.58 Thousand USD
|
551944.756%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Immuneering Corporation
|
-764.13 Thousand USD
|
59739.745%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
Silo Pharma, Inc.
|
66.26 Thousand USD
|
-687648.936%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-3.94 Million USD
|
11660.741%
|
Belite Bio, Inc
|
-399 Thousand USD
|
114318.034%
|
Pharming Group N.V.
|
220.1 Million USD
|
-107.052%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
Bionomics Limited
|
-434.44 Thousand USD
|
104998.378%
|
Pyxis Oncology, Inc.
|
-2 Million USD
|
22886.498%
|
uniQure N.V.
|
2.21 Million USD
|
-20474.716%
|
Windtree Therapeutics, Inc.
|
-82 Thousand USD
|
555868.238%
|
GeoVax Labs, Inc.
|
-20.72 Million USD
|
2299.388%
|
Poseida Therapeutics, Inc.
|
-92.06 Million USD
|
594.987%
|
Altimmune, Inc.
|
-65.37 Million USD
|
797.123%
|
Anebulo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Alpha Tau Medical Ltd.
|
-1.07 Million USD
|
42532.957%
|
Peak Bio, Inc.
|
367.76 Thousand USD
|
-123817.447%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
FibroBiologics, Inc. Common Stock
|
-437 Thousand USD
|
104386.031%
|
Benitec Biopharma Inc.
|
108 Thousand USD
|
-421872.181%
|
Zura Bio Limited
|
- USD
|
-Infinity%
|
Amicus Therapeutics, Inc.
|
362.03 Million USD
|
-25.882%
|
Salarius Pharmaceuticals, Inc.
|
-10.05 Thousand USD
|
4534275.256%
|
Compugen Ltd.
|
31.45 Million USD
|
-1348.832%
|
Elevai Labs, Inc. Common Stock
|
1.13 Million USD
|
-40067.283%
|
argenx SE
|
1.1 Billion USD
|
58.887%
|
Zevra Therapeutics, Inc.
|
24.51 Million USD
|
-1758.908%
|
Nuvectis Pharma, Inc.
|
-22.89 Million USD
|
2090.348%
|
Spyre Therapeutics, Inc.
|
-78 Thousand USD
|
584369.173%
|
NKGen Biotech, Inc. Common Stock
|
-1.2 Million USD
|
37982.789%
|
Madrigal Pharmaceuticals, Inc.
|
-527 Thousand USD
|
86576.272%
|
PolyPid Ltd.
|
-1.82 Million USD
|
25112.621%
|
Aileron Therapeutics, Inc.
|
-119 Thousand USD
|
383066.349%
|
Plus Therapeutics, Inc.
|
-4.77 Million USD
|
9640.087%
|
Forte Biosciences, Inc.
|
-9000.00 USD
|
5063766.167%
|
Dianthus Therapeutics, Inc.
|
2.47 Million USD
|
-18343.139%
|
Instil Bio, Inc.
|
-4.75 Million USD
|
9682.211%
|
Elevation Oncology, Inc.
|
-39 Thousand USD
|
1168638.346%
|
Immunome, Inc.
|
-8.9 Million USD
|
5216.537%
|
Verona Pharma plc
|
-679.62 Thousand USD
|
67156.189%
|
Enveric Biosciences, Inc.
|
-408.03 Thousand USD
|
111790.306%
|
enGene Holdings Inc. Warrants
|
-175 Thousand USD
|
260517.117%
|
Shattuck Labs, Inc.
|
-2.38 Million USD
|
19208.174%
|
LENZ Therapeutics, Inc.
|
-2.4 Million USD
|
19033.525%
|
Design Therapeutics, Inc.
|
-537 Thousand USD
|
84965.913%
|
Leap Therapeutics, Inc.
|
-427 Thousand USD
|
106828.327%
|
Seelos Therapeutics, Inc.
|
2.14 Million USD
|
-21136.251%
|
Achilles Therapeutics plc
|
-4.73 Million USD
|
9732.303%
|
Fractyl Health, Inc. Common Stock
|
43 Thousand USD
|
-1059737.105%
|
Rani Therapeutics Holdings, Inc.
|
-822 Thousand USD
|
55541.6%
|
MoonLake Immunotherapeutics
|
-13.15 Thousand USD
|
3463619.95%
|
Beam Therapeutics Inc.
|
-59.67 Million USD
|
863.725%
|
Moolec Science SA
|
-143.3 Thousand USD
|
318113.995%
|
Longboard Pharmaceuticals, Inc.
|
-5000.00 USD
|
9114699.1%
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
Aadi Bioscience, Inc.
|
21.54 Million USD
|
-2015.247%
|
Enliven Therapeutics, Inc.
|
-297 Thousand USD
|
153544.429%
|
Iovance Biotherapeutics, Inc.
|
-9.56 Million USD
|
4864.06%
|
Taysha Gene Therapies, Inc.
|
14.08 Million USD
|
-3136.718%
|
Inovio Pharmaceuticals, Inc.
|
-2.67 Million USD
|
17158.775%
|
Athira Pharma, Inc.
|
-969 Thousand USD
|
47130.955%
|
HCW Biologics Inc.
|
-574.82 Thousand USD
|
79381.651%
|
XOMA Corporation
|
3.86 Million USD
|
-11703.418%
|
NeurAxis, Inc.
|
2.15 Million USD
|
-21030.853%
|
Lumos Pharma, Inc.
|
2 Million USD
|
-22607.023%
|
enGene Holdings Inc. Common Stock
|
-175 Thousand USD
|
260517.117%
|
180 Life Sciences Corp.
|
-105.67 Thousand USD
|
431356.167%
|
Nektar Therapeutics
|
53.47 Million USD
|
-752.182%
|
NKGen Biotech, Inc. Warrants
|
-1.2 Million USD
|
37982.789%
|
Opiant Pharmaceuticals, Inc.
|
31.65 Million USD
|
-1339.507%
|
Arvinas, Inc.
|
71.8 Million USD
|
-534.721%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Palisade Bio, Inc.
|
246 Thousand USD
|
-185156.079%
|
Nutriband Inc.
|
862.1 Thousand USD
|
-52762.465%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
CG Oncology, Inc. Common stock
|
-45.54 Million USD
|
1100.549%
|
Tourmaline Bio, Inc.
|
-33 Thousand USD
|
1381099.864%
|
Merus N.V.
|
-83.46 Million USD
|
646.039%
|
Omega Therapeutics, Inc.
|
-62.77 Million USD
|
825.974%
|
Neurogene Inc.
|
-3.26 Million USD
|
14070.875%
|
Mirum Pharmaceuticals, Inc.
|
139.33 Million USD
|
-227.075%
|
Kintara Therapeutics, Inc.
|
-55 Thousand USD
|
828699.918%
|
CervoMed Inc.
|
-1.29 Million USD
|
35328.853%
|
CARGO Therapeutics, Inc. Common Stock
|
-3.69 Million USD
|
12443.715%
|
Sesen Bio, Inc.
|
40 Million USD
|
-1039.325%
|
Quince Therapeutics, Inc.
|
-322 Thousand USD
|
141631.042%
|
Rezolute, Inc.
|
-36 Thousand USD
|
1266016.542%
|
Clene Inc.
|
533 Thousand USD
|
-85402.806%
|
Indaptus Therapeutics, Inc.
|
-1284.00 USD
|
35493087.15%
|
BeyondSpring Inc.
|
1.75 Million USD
|
-25926.839%
|
Synlogic, Inc.
|
-1.92 Million USD
|
23786.588%
|
Allarity Therapeutics, Inc.
|
-37 Thousand USD
|
1231802.581%
|
Phio Pharmaceuticals Corp.
|
-6.33 Million USD
|
7297.251%
|
Peak Bio, Inc.
|
367.76 Thousand USD
|
-123817.447%
|
Werewolf Therapeutics, Inc.
|
-18.96 Million USD
|
2503.259%
|
Krystal Biotech, Inc.
|
47.6 Million USD
|
-857.315%
|
Karyopharm Therapeutics Inc.
|
141.09 Million USD
|
-223.004%
|
SpringWorks Therapeutics, Inc.
|
5.02 Million USD
|
-8969.253%
|
Lipella Pharmaceuticals Inc.
|
-2.58 Million USD
|
17701.059%
|
MannKind Corporation
|
136.19 Million USD
|
-234.626%
|
Ikena Oncology, Inc.
|
-50.49 Million USD
|
1002.579%
|
Cyclerion Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Gyre Therapeutics, Inc.
|
108.81 Million USD
|
-318.816%
|
Gossamer Bio, Inc.
|
-4.38 Million USD
|
10492.929%
|
CohBar, Inc.
|
- USD
|
-Infinity%
|
Cognition Therapeutics, Inc.
|
-252 Thousand USD
|
180945.22%
|
NRx Pharmaceuticals, Inc.
|
-5000.00 USD
|
9114699.1%
|
Legend Biotech Corporation
|
140.92 Million USD
|
-223.376%
|
Mural Oncology plc
|
-2.56 Million USD
|
17853.407%
|
Disc Medicine, Inc.
|
-100 Thousand USD
|
455829.955%
|
Champions Oncology, Inc.
|
20.75 Million USD
|
-2095.866%
|
REGENXBIO Inc.
|
53.02 Million USD
|
-759.398%
|
Ensysce Biosciences, Inc.
|
-5.35 Million USD
|
8607.261%
|
Anavex Life Sciences Corp.
|
- USD
|
-Infinity%
|
Cellectar Biosciences, Inc.
|
-192.37 Thousand USD
|
236996.663%
|
Edgewise Therapeutics, Inc.
|
-1.73 Million USD
|
26412.353%
|
Vaxart, Inc.
|
-60.76 Million USD
|
850.012%
|
PharmaCyte Biotech, Inc.
|
- USD
|
-Infinity%
|
Aldeyra Therapeutics, Inc.
|
-262.78 Thousand USD
|
173526.423%
|
Cellectis S.A.
|
18 Thousand USD
|
-2531733.083%
|
Longeveron Inc.
|
221 Thousand USD
|
-206112.649%
|
Repare Therapeutics Inc.
|
-80.07 Million USD
|
669.164%
|
Sarepta Therapeutics, Inc.
|
1.09 Billion USD
|
58.304%
|
Inozyme Pharma, Inc.
|
-1.29 Million USD
|
35318.698%
|
Revolution Medicines, Inc.
|
-399.66 Million USD
|
214.028%
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
Third Harmonic Bio, Inc.
|
-35 Thousand USD
|
1302185.586%
|
ArriVent BioPharma, Inc. Common Stock
|
- USD
|
-Infinity%
|
AN2 Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Anixa Biosciences, Inc.
|
49 Thousand USD
|
-929961.133%
|
Vertex Pharmaceuticals Incorporated
|
8.6 Billion USD
|
94.705%
|
Denali Therapeutics Inc.
|
-93.34 Million USD
|
588.221%
|
Revelation Biosciences, Inc.
|
-25.04 Thousand USD
|
1819453.886%
|
Veru Inc.
|
7.56 Million USD
|
-5923.451%
|
Corvus Pharmaceuticals, Inc.
|
-151 Thousand USD
|
301907.917%
|
Cingulate Inc.
|
-582.91 Thousand USD
|
78280.8%
|
Passage Bio, Inc.
|
-3.72 Million USD
|
12347.513%
|
Context Therapeutics Inc.
|
-12.04 Thousand USD
|
3783975.415%
|
Exicure, Inc.
|
-1.42 Million USD
|
32125.998%
|
Day One Biopharmaceuticals, Inc.
|
-383 Thousand USD
|
119089.544%
|
Oramed Pharmaceuticals Inc.
|
2.7 Million USD
|
-16760.154%
|
Scinai Immunotherapeutics Ltd.
|
-512.67 Thousand USD
|
88992.564%
|
Nuvalent, Inc.
|
- USD
|
-Infinity%
|
ABVC BioPharma, Inc.
|
-149.6 Thousand USD
|
304718.069%
|
Carisma Therapeutics, Inc.
|
-59.2 Million USD
|
869.736%
|
Unicycive Therapeutics, Inc.
|
391 Thousand USD
|
-116454.976%
|
OmniAb, Inc.
|
14.66 Million USD
|
-3007.179%
|
Anew Medical, Inc.
|
- USD
|
-Infinity%
|
Fennec Pharmaceuticals Inc.
|
19.99 Million USD
|
-2179.448%
|
Lipocine Inc.
|
-2.85 Million USD
|
16085.936%
|
Lexeo Therapeutics, Inc. Common Stock
|
-1.84 Million USD
|
24827.616%
|
Nautilus Biotechnology, Inc.
|
-5.7 Million USD
|
8088.255%
|
SAB Biotherapeutics, Inc.
|
-1.5 Million USD
|
30355.107%
|
G1 Therapeutics, Inc.
|
75.31 Million USD
|
-505.09%
|
Bellerophon Therapeutics, Inc.
|
-65 Thousand USD
|
701223.008%
|
Sage Therapeutics, Inc.
|
84.29 Million USD
|
-440.631%
|
Ocugen, Inc.
|
-33.53 Million USD
|
1458.887%
|
Mind Medicine (MindMed) Inc.
|
-3.16 Million USD
|
14512.712%
|
Q32 Bio Inc.
|
578 Thousand USD
|
-78746.013%
|
Brainstorm Cell Therapeutics Inc.
|
-265 Thousand USD
|
172073.568%
|
Alumis Inc. Common Stock
|
-1.28 Million USD
|
35592.987%
|
Equillium, Inc.
|
35.95 Million USD
|
-1167.395%
|
Kyverna Therapeutics, Inc.
|
-1.7 Million USD
|
26797.713%
|
Coya Therapeutics, Inc.
|
500.67 Thousand USD
|
-90922.383%
|
CNS Pharmaceuticals, Inc.
|
-4134.00 USD
|
11024046.662%
|
Dominari Holdings Inc.
|
2.03 Million USD
|
-22250.66%
|
Edesa Biotech, Inc.
|
-183.47 Thousand USD
|
248493.455%
|
vTv Therapeutics Inc.
|
-13.59 Million USD
|
3452.188%
|
Bio-Techne Corporation
|
773.07 Million USD
|
41.05%
|
Agios Pharmaceuticals, Inc.
|
17.31 Million USD
|
-2531.387%
|
Harmony Biosciences Holdings, Inc.
|
460.78 Million USD
|
1.097%
|
Prelude Therapeutics Incorporated
|
-1.16 Million USD
|
39084.598%
|
Candel Therapeutics, Inc.
|
-23.98 Million USD
|
2000.459%
|
iTeos Therapeutics, Inc.
|
11.69 Million USD
|
-3796.127%
|
Nkarta, Inc.
|
-5.86 Million USD
|
7865.036%
|
BioCardia, Inc.
|
-7.24 Million USD
|
6386.798%
|
Iterum Therapeutics plc
|
-1.75 Million USD
|
26141.712%
|